GE HealthCare Technologies (NASDAQ:GEHC) Announces Earnings Results, Beats Expectations By $0.19 EPS

GE HealthCare Technologies (NASDAQ:GEHC) announced its earnings results on Thursday. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19, Zacks reports. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies updated its FY 2025 guidance to 4.610-4.750 EPS.

GE HealthCare Technologies Trading Up 8.8 %

NASDAQ GEHC opened at $93.48 on Friday. GE HealthCare Technologies has a one year low of $74.51 and a one year high of $94.80. The company has a 50-day simple moving average of $83.81 and a 200-day simple moving average of $85.44. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm has a market capitalization of $42.71 billion, a PE ratio of 25.68, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is 3.85%.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of recent analyst reports. Citigroup increased their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $97.31.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.